guanfacine has been researched along with Diabetes Mellitus, Type 1 in 1 studies
Guanfacine: A centrally acting antihypertensive agent with specificity towards ADRENERGIC ALPHA-2 RECEPTORS.
Diabetes Mellitus, Type 1: A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dvorák, I | 1 |
| Podrouzková, B | 1 |
| Kocourková, J | 1 |
| Kubesová, H | 1 |
| Spác, J | 1 |
| Nĕmcová, H | 1 |
| Blaha, M | 1 |
1 trial available for guanfacine and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
Guanfacine in the treatment of hypertensives with a pronounced response to exercise and diabetes mellitus.
Topics: Antihypertensive Agents; Blood Pressure; Clinical Trials as Topic; Diabetes Mellitus, Type 1; Diabet | 1987 |